Literature DB >> 20409957

Experimental animal models of hypertension.

Kiran V Sarikonda1, Ralph E Watson, Oluchi C Opara, Donald J Dipette.   

Abstract

Hypertension (HTN) and cardiovascular disease are the most common causes of death in developed countries. The use of experimental animal models of HTN has provided valuable information regarding many aspects of HTN, including etiology, pathophysiology, complications, and treatment. Because the etiology of HTN is heterogeneous, many experimental animal models have been developed to mimic the many facets of human HTN. The choice of animal model will be determined by the research question, monetary limitations, and technical expertise. The categories of models of HTN are: renovascular, renal parenchymal, pharmacologically induced, environmentally induced, and genetic. There are considerable differences between HTN in animals and humans, including differences in homeostatic mechanisms and pathophysiology; therefore, a thorough understanding of the animal models and rigorous analysis is required before extrapolating the finding in animals to humans.

Entities:  

Year:  2009        PMID: 20409957     DOI: 10.1016/j.jash.2009.02.003

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  14 in total

1.  Temporal Expression and Cellular Localization of PAPPA2 in the Developing Kidney of Rat.

Authors:  Vikash Kumar; Chun Yang; Allen W Cowley
Journal:  J Histochem Cytochem       Date:  2020-01-28       Impact factor: 2.479

2.  Antihypertensive Effect and Safety Evaluation of Rice Bran Hydrolysates from Sang-Yod Rice.

Authors:  Gulladawan Jan-On; Weerapon Sangartit; Poungrat Pakdeechote; Veerapol Kukongviriyapan; Ketmanee Senaphan; Orachorn Boonla; Chakree Thongraung; Upa Kukongviriyapan
Journal:  Plant Foods Hum Nutr       Date:  2020-03       Impact factor: 3.921

Review 3.  Nephron number, hypertension, and CKD: physiological and genetic insight from humans and animal models.

Authors:  Xuexiang Wang; Michael R Garrett
Journal:  Physiol Genomics       Date:  2017-01-27       Impact factor: 3.107

4.  Visualization of stimulus-specific heterogeneous activation of individual vascular smooth muscle cells in aortic tissues.

Authors:  Satoshi Komatsu; Toshio Kitazawa; Mitsuo Ikebe
Journal:  J Cell Physiol       Date:  2017-07-14       Impact factor: 6.384

5.  Differences in left ventricular cardiomyocyte loss induced by chronic intermittent hypoxia between spontaneously hypertensive and Wistar-Kyoto rats.

Authors:  Tsung-I Chen; Ching-Jung Lai; Chien-Ju Hsieh; Ke-Li Tsai; Kun-Ta Yang
Journal:  Sleep Breath       Date:  2010-12-07       Impact factor: 2.816

6.  Association of Mbo I-RFLP at the Renin Locus (rs2368564) with Essential Hypertension.

Authors:  Deepak N Parchwani; Digisha D Patel; Jairam Rawtani; Nirupama Dikshit
Journal:  Indian J Clin Biochem       Date:  2016-01-07

7.  Consistent antioxidant and antihypertensive effects of oral sodium nitrite in DOCA-salt hypertension.

Authors:  Jefferson H Amaral; Graziele C Ferreira; Lucas C Pinheiro; Marcelo F Montenegro; Jose E Tanus-Santos
Journal:  Redox Biol       Date:  2015-06-23       Impact factor: 11.799

8.  Inhibition of the Prostaglandin Transporter PGT Lowers Blood Pressure in Hypertensive Rats and Mice.

Authors:  Yuling Chi; Jean-Francois Jasmin; Yoshinori Seki; Michael P Lisanti; Maureen J Charron; David J Lefer; Victor L Schuster
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

9.  Super, red palm and palm oleins improve the blood pressure, heart size, aortic media thickness and lipid profile in spontaneously hypertensive rats.

Authors:  Chee-Meng Boon; Mei-Han Ng; Yuen-May Choo; Shiueh-Lian Mok
Journal:  PLoS One       Date:  2013-02-11       Impact factor: 3.240

10.  Histopathological characteristics of renal changes in human renin-angiotensinogen double transgenic rats.

Authors:  Tomoaki Tochitani; Masaya Mori; Koichi Matsuda; Mami Kouchi; Yuta Fujii; Izumi Matsumoto
Journal:  J Toxicol Pathol       Date:  2015-12-12       Impact factor: 1.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.